Skip to main content
. 2018 May 31;2018(5):CD011680. doi: 10.1002/14651858.CD011680.pub2

Comparison 2. AB 103 versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Mortality within 30 days 1 43 Risk Ratio (M‐H, Random, 95% CI) 0.34 [0.05, 2.16]
2 Proportion of patients who experienced serious adverse events 1 43 Risk Ratio (M‐H, Random, 95% CI) 1.49 [0.52, 4.27]